| 111 Elekta: Pioneering Cancer Care with Innovation and Partnership In the landscape of radiation therapy Elekta stands as a stalwart innovator, shaping the future of cancer care globally. Among its longstanding partnerships the bond with Auckland Radiation Oncology (ARO) reflects Elekta's commitment to providing cutting-edge solutions and unwavering support. "They have been a close partner of ours for many years, being one of the first sites in New Zealand to install all of our equipment," says Jessica Synge, Elekta New Zealand Sales Account Manager and a former radiation therapist. “This partnership underscores Elekta's dedication to collaborating with healthcare providers to advance the field of radiation therapy.” Elekta's reputation as an innovator in radiation therapy equipment is well earned. With a global presence, the company offers a continuum of care and complete solutions. One of its latest innovations, the Elekta Unity machine, represents a quantum leap in imaging technology. While traditional radiotherapy machines provide CT-quality imaging, the Unity machine offers MR-quality imaging, enabling physicians to visualise anatomy with unprecedented detail. Jessica says the benefits of Elekta Unity are manifold. “It allows for improved outcomes with reduced margins and safe dose escalation, treating more patients with fewer fractions. The machine provides doctors with options to shorten treatments, administer larger doses with precision, and enhance overall treatment efficacy,” she says. Elekta's commitment to a culture of innovation is evident in its range of linear accelerators, which aim to let more patients benefit from high-precision, personalized treatments. These machines go beyond being mere equipment, offering comprehensive radiation treatment planning and review software, quality assurance tools, and extensive service options. Jessica says that Elekta's versatile solutions, marked by compatibility with machinery and software from other brands, give customers the freedom to choose the best options for their needs. This flexibility, combined with a commitment to openness, allows Elekta to offer personalized cancer care across all treatment modalities. Elekta's commitment extends beyond equipment provision. The Elekta Care program transforms the experience for healthcare professionals, ensuring operational efficiency and patient treatments that stay on schedule. Elekta Care also encompasses a proactive approach to innovation, leveraging artificial intelligence through the Elekta IntelliMax® solution. This solution identifies and addresses issues before they occur, accelerating problem resolution and ensuring the highest levels of system efficiency and availability, says Jessica. “Elekta's partnership approach is evident in its dedication beyond product delivery with Elekta working closely with healthcare providers at every stage. This commitment ensures that clients become part of a global network, facilitating the exchange of knowledge, insights, and best practices,” explains Jessica. At the core of Elekta's mission is a united purpose — hope for everyone dealing with cancer. The company’s vision is a world where everyone has access to the best cancer care, and its mission is to improve patient lives by collaborating with customers and partners. In line with this mission, Elekta has laid out its ACCESS 2025 strategy, focusing on closing the access gap, elevating cancer care, and increasing patient participation in their own care. The milestones include providing access to radiation therapy for an additional 300 million people through 825 Elekta linacs in underserved markets, doubling the clinical usage of short-course treatment, and quadrupling the usage of adaptive treatments among Elekta customers. “Elekta has a true commitment to innovation, collaboration, and a united mission to bring hope to everyone dealing with cancer,” says Jessica. “As Elekta continues to push the boundaries of precision radiation therapy, it aims to remain a beacon of progress in the quest for accessible and effective cancer care worldwide.”
RkJQdWJsaXNoZXIy NDc2Mzg=